Download PDF
Z Gastroenterol 2011; 49(5): 627-632
DOI: 10.1055/s-0031-1273324
Mitteilungen

© Georg Thieme Verlag KG Stuttgart · New York

Diagnose und Behandlung von Eisenmangel und Anämie bei chronisch entzündlichen Darmerkrankungen. Konsensus der österreichischen Arbeitsgruppe für CED

Diagnosis and Treatment of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases. Consensus of the Austrian IBD Working PartyC. Gasche1 , 2 , R. Evstatiev1 , T. Haas3 , A. Kaser4 , P. Knoflach5 , W. Petritsch6 , G. Weiss7 , W. Reinisch1
  • 1Medizinische Universität Wien, Klinik Innere Medizin 3, Abteilung Gastroenterologie und Hepatologie
  • 2Medizinische Universität Wien, Christian Doppler Labor für Molekulare Carzinom Chemoprävention
  • 3Paracelsus Medizinische Privatuniversität Salzburg, Klinik für Innere Medizin 1, SALK
  • 4Medizinische Universitätsklinik Innsbruck, Univ.-Klinik f. Innere Medizin II
  • 5Klinikum Wels, Abt. Innere Medizin I
  • 6Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Gastroenterologie und Hepatologie
  • 7Medizinische Universität Innsbruck, Department für Innere Medizin, Klinische Infektiologie und Immunologie
Further Information

Publication History

Manuskript eingetroffen: 2.12.2010

Manuskript akzeptiert: 15.3.2011

Publication Date:
27 April 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Eisenmangel mit und ohne Anämie ist ein häufiges Problem bei Patienten mit chronisch entzündlichen Darmerkrankungen (CED) und kann mit einer erheblichen Einschränkung der Lebensqualität und Leistungsfähigkeit verbunden sein. Die Arbeitsgruppe für CED der Österreichischen Gesellschaft für Gatroenterologie und Hepatologie (ÖGGH) erarbeitete 5 Konsensus-Statements zu folgenden Inhalten: Diagnose von Eisenmangel und Anämie, Screening auf Eisenmangel, Behandlung von Eisenmangel und Behandlungsziele. Die klinische Bedeutung der intravenösen Eisensubstitution bei CED in Bezug auf Effektivität und Compliance wurde diskutiert.

Abstract

Iron deficiency with and without anAemia is a common burden of patients with inflammatory bowel diseases (IBD) and has considerable impact on their quality of life and the ability to perform. The IBD working group of the Austrian Society of Gastroenterology and Hepatology developed five consensus statements on the following topics: (i) diagnosis of iron deficiency and (ii) anaemia, (iii) screening of iron deficiency, (iv) treatment of iron deficiency and (v) therapeutic goals. The clinical importance of intravenous iron replacement therapy in IBD with regard to effectiveness and compliance was discussed.

Schlüsselwörter

Colitis ulcerosa - extraintestinale Manifestation - Morbus Crohn - chronisch entzündliche Darmerkrankung - Eisenmangel

Key words

ulcerative colitis - extraintestinal manifestations - Crohn’s disease - inflammatory bowel disease - Iron deficiency

Literatur

  • 1 Gasche C. Anemia in IBD: the overlooked villain.  Inflamm Bowel Dis. 2000;  6 142-150
    Google Scholar
  • 2 Gasche C, Lomer M C, Cavill I et al. Iron, anaemia, and inflammatory bowel diseases.  Gut. 2004;  53 1190-1197
    Google Scholar
  • 3 Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease.  Aliment Pharmacol Ther. 2006;  24 1507-1523
    Google Scholar
  • 4 Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature.  Am J Med. 2004;  116 (Suppl 7A) 44S-9S
    Google Scholar
  • 5 Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease.  Haematologica. 2010;  95 175-178
    Google Scholar
  • 6 Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.  Inflamm Bowel Dis. 2007;  13 1545-1553
    Google Scholar
  • 7 WHO, UNICEF, and UNU .Iron Deficiency Anemia: Assessment, Prevention and Control. Report of a joint WHO/UNICEF/UNU consultation. Geneva: World Health Organization; 1998 Conference Proceeding
    Google Scholar
  • 8 Blanc B, Finch C A, Hallberg L et al. Nutritional anaemias. Report of a WHO Scientific Group.  WHO Tech Rep Ser. 1968;  405 1-40
    Google Scholar
  • 9 Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?.  Blood. 2006;  107 1747-1750
    Google Scholar
  • 10 Beutler E, Felitti V J, Koziol J A et al. Penetrance of 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA.  Lancet. 2002;  359 211-218
    Google Scholar
  • 11 Waalen J, Felitti V, Gelbart T et al. Penetrance of hemochromatosis.  Blood Cells Mol Dis. 2002;  29 418-432
    Google Scholar
  • 12 Hollowell J G, Assendelft O W, Gunter E W et al. Hematological and iron-related analytes – reference data for persons aged 1 year and over: United States, 1988 – 94.  Vital Health Stat. 2005;  11 1-156
    Google Scholar
  • 13 Gomollon van F, Gisbert J P. Anemia and inflammatory bowel diseases.  World J Gastroenterol. 2009;  15 4659-4665
    Google Scholar
  • 14 Weiss G, Goodnough L T. Anemia of chronic disease.  N Engl J Med. 2005;  352 1011-1023
    Google Scholar
  • 15 Semrin G, Fishman D S, Bousvaros A et al. Impaired intestinal iron absorption in Crohn’s disease correlates with disease activity and markers of inflammation.  Inflamm Bowel Dis. 2006;  12 1101-1106
    Google Scholar
  • 16 Nemeth E, Tuttle M S, Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.  Science. 2004;  306 2090-2093
    Google Scholar
  • 17 Theurl I, Aigner E, Theurl M et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.  Blood. 2009;  113 5277-5286
    Google Scholar
  • 18 Busbridge M, Griffiths C, Ashby D et al. Development of a novel immunoassay for the iron regulatory peptide hepcidin.  Br J Biomed Sci. 2009;  66 150-157
    Google Scholar
  • 19 Hansen T M, Hansen N E, Birgens H S et al. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis.  Scand J Rheumatol. 1983;  12 353-359
    Google Scholar
  • 20 Bartels U, Pedersen N S, Jarnum S. Iron absorption and serum ferritin in chronic inflammatory bowel disease.  Scand J Gastroenterol. 1978;  13 649-656
    Google Scholar
  • 21 Schaefer R M, Schaefer L. Hypochromic red blood cells and reticulocytes.  Kidney Int Suppl. 1999;  69 S44-S48
    Google Scholar
  • 22 Bermejo F, Garcia-Lopez S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases.  World J Gastroenterol. 2009;  15 4638-4643
    Google Scholar
  • 23 Devalia V. Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay.  BMJ. 2006;  333 385-386
    Google Scholar
  • 24 Bruner A B, Joffe A, Duggan A K et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls.  Lancet. 1996;  348 992-996
    Google Scholar
  • 25 Erichsen K, Hausken T, Ulvik R J et al. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease.  Scand J Gastroenterol. 2003;  38 543-548
    Google Scholar
  • 26 Erichsen K, Ulvik R J, Grimstad T et al. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.  Aliment Pharmacol Ther. 2005;  22 831-838
    Google Scholar
  • 27 De Silva A D, Tsironi E, Feakins R M et al. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial.  Aliment Pharmacol Ther. 2005;  22 1097-1105
    Google Scholar
  • 28 Seril D N, Liao J, West A B et al. High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis.  J Clin Gastroenterol. 2006;  40 391-397
    Google Scholar
  • 29 Werner T, Wagner S J, Martinez I et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn’s disease-like ileitis.  Gut. 2011;  60 325-333
    Google Scholar
  • 30 Silva A D, Tsironi de E, Feakins R M et al. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial.  Aliment Pharmacol Ther. 2005;  22 1097-1105
    Google Scholar
  • 31 Rimon E, Kagansky N, Kagansky M et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians.  Am J Med. 2005;  118 1142-1147
    Google Scholar
  • 32 Zlotkin S, Arthur P, Antwi K Y et al. Randomized, controlled trial of single versus 3-times-daily ferrous sulfate drops for treatment of anemia.  Pediatrics. 2001;  108 613-616
    Google Scholar
  • 33 Schreiber S, Howaldt S, Schnoor M et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.  The New England Journal of Medicine. 1996;  334 619-623
    Google Scholar
  • 34 Schroder O, Mickisch O, Seidler U et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease – a randomized, controlled, open-label, multicenter study.  Am J Gastroenterol. 2005;  100 2503-2509
    Google Scholar
  • 35 Kulnigg S, Stoinov S, Simanenkov V et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.  Am J Gastroenterol. 2008;  103 1182-1192
    Google Scholar
  • 36 Lindgren S, Wikman O, Befrits R et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.  Scand J Gastroenterol. 2009;  44 (7) 838-895
    Google Scholar
  • 37 Bayraktar U D, Bayraktar S. Treatment of iron deficiency anemia associated with gastrointestinal tract diseases.  World J Gastroenterol. 2010;  16 2720-2725
    Google Scholar
  • 38 Wells C W, Lewis S, Barton J R et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.  Inflamm Bowel Dis. 2006;  12 123-130
    Google Scholar
  • 39 Gisbert J P, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.  Am J Gastroenterol. 2008;  103 1299-1307
    Google Scholar
  • 40 Kulnigg S, Teischinger L, Dejaco C et al. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.  Am J Gastroenterol. 2009;  104 1460-1467
    Google Scholar
  • 41 Evstatiev R, Marteau P, Iqbal T et al. Efficacy and safety of standardised ferric carboxymaltose doses vs. individually calculated iron sucrose doses for IBD-associated iron deficiency anaemia: A multicentre, randomised controlled trial.  Gut. 2010;  59 A-5075
    Google Scholar
  • 42 Koutroubakis I E, Oustamanolakis P, Karakoidas C et al. Safety and Efficacy of Total-Dose Infusion of Low Molecular Weight Iron Dextran for Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease.  Dig Dis Sci. 2010;  55 (8) 2327-2331
    Google Scholar
  • 43 Lyseng-Williamson K A, Keating G M. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.  Drugs. 2009;  69 739-756
    Google Scholar
  • 44 Ganzoni A M. Intravenous iron-dextran: therapeutic and experimental possibilities.  Schweiz Med Wochenschr. 1970;  100 301-303
    Google Scholar
  • 45 Ali M, Rigolosi R, Fayemi A O et al. Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy.  Lancet. 1982;  1 652-655
    Google Scholar
  • 46 Besarab A, Bolton W K, Browne J K et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.  N Engl J Med. 1998;  339 584-590
    Google Scholar
  • 47 Locatelli F, Pisoni R L, Combe C et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).  Nephrol Dial Transplant. 2004;  19 121-132
    Google Scholar
  • 48 Michael B, Coyne D W, Fishbane S et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.  Kidney Int. 2002;  61 1830-1839
    Google Scholar
  • 49 Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia.  Lancet. 2007;  369 1502-1504
    Google Scholar
  • 50 Chertow G M, Mason P D, Vaage-Nilsen O et al. Update on adverse drug events associated with parenteral iron.  Nephrol Dial Transplant. 2006;  21 378-382
    Google Scholar
  • 51 Bailie G R, Clark J A, Lane C E et al. Hypersensitivity reactions and deaths associated with intravenous iron preparations.  Nephrol Dial Transplant. 2005;  20 1443-1449
    Google Scholar
  • 52 Weiss G, Gordeuk V R. Benefits and risks of iron therapy for chronic anaemias.  Eur J Clin Invest. 2005;  35 (Suppl 3) 36-45
    Google Scholar
  • 53 Sazawal S, Black R E, Ramsan M et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial.  Lancet. 2006;  367 133-143
    Google Scholar
  • 54 Carrier J, Aghdassi E, Platt I et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis.  Aliment Pharmacol Ther. 2001;  15 1989-1999
    Google Scholar
  • 55 Seril D N, Liao J, Ho K L et al. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice.  Dig Dis Sci. 2002;  47 1266-1278
    Google Scholar
  • 56 Seril D N, Liao J, Yang C S et al. Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet.  Dig Dis Sci. 2005;  50 696-707
    Google Scholar
  • 57 Carrier J, Aghdassi E, Cullen J et al. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis.  J Nutr. 2002;  132 3146-3150
    Google Scholar
  • 58 Kabat G C, Miller A B, Jain M et al. A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women.  Br J Cancer. 2007;  97 118-122
    Google Scholar
  • 59 Cross A J, Gunter M J, Wood R J et al. Iron and colorectal cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study.  Int J Cancer. 2006;  118 3147-3152
    Google Scholar
  • 60 Senesse P, Meance S, Cottet V et al. High dietary iron and copper and risk of colorectal cancer: a case-control study in Burgundy, France.  Nutr Cancer. 2004;  49 66-71
    Google Scholar
  • 61 Kato I, Dnistrian A M, Schwartz M et al. Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study.  Int J Cancer. 1999;  80 693-698
    Google Scholar
  • 62 Seril D N, Liao J, West A B et al. High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis.  J Clin Gastroenterol. 2006;  40 391-397
    Google Scholar
  • 63 Lakatos L, Mester G, Erdelyi Z et al. Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients.  Orv Hetil. 2006;  147 175-181
    Google Scholar
  • 64 Stein J, Hartmann F, Dignass A U. Diagnosis and management of iron deficiency anemia in patients with IBD.  Nat Rev Gastroenterol Hepatol. 2010;  7 599-610
    Google Scholar

Dr. Christoph Gasche

KIM3, Abt. für Gastroenterologie und Hepatologie

Währinger Gürtel 18 – 20

1090 Wien

Österreich

Email: christoph.gasche@meduniwien.ac.at

      >